SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-017496
Filing Date
2024-05-17
Accepted
2024-05-17 16:31:50
Documents
6
Effectiveness Date
2024-05-17
Reference 429
333-270965

Document Format Files

Seq Description Document Type Size
1 FORM S-8 rvph20240326_s8.htm S-8 56869
2 EXHIBIT 5.1 ex_645064.htm EX-5.1 7610
3 EXHIBIT 23.1 ex_645065.htm EX-23.1 2446
4 EXHIBIT 23.2 ex_645066.htm EX-23.2 2715
5 EXHIBIT FILING FEES ex_645067.htm EX-FILING FEES 29850
6 pic1.jpg GRAPHIC 7171
  Complete submission text file 0001437749-24-017496.txt   110717
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279508 | Film No.: 24960334
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)